Discusses the control of glycemia in patients with type 2 diabetes. Degree of genetics-influenced insulin resistance; "Legacy-effect" of glucose-lowering therapies; Mortality risk factors; Signaling pathways of insulin action; Insulin sensitivity; Glucagon-like peptide 1; Treatment of obesity.